Nautilus Biotechnology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q4 2024 | 2 | -$0.16 | -$0.15 | -$0.16 |
| Q1 2025 | 2 | -$0.20 | -$0.15 | -$0.18 |
| Q2 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q4 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Nautilus Biotechnology, Inc. Earnings Date And Information
Nautilus Biotechnology, Inc. last posted its earnings results on Tuesday, October 29th, 2024. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.17 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Nautilus Biotechnology, Inc. has generated $-1 earnings per share over the last year ($-0.51 diluted earnings per share) and currently has a price-to-earnings ratio of -4.29. Nautilus Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Nautilus Biotechnology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q3 2024 | -$0.17 | -$0.13 | 0.04 | $1.83 M | $0 |
| 07/30/2024 | Q2 2024 | -$0.16 | -$0.14 | 0.02 | $391,667 | $0 |
| 04/30/2024 | Q1 2024 | -$0.16 | -$0.15 | 0.01 | $0 | |
| 02/28/2024 | Q4 2023 | -$0.16 | -$0.14 | 0.02 | $8.21 M | |
| 10/31/2023 | Q3 2023 | -$0.18 | -$0.13 | 0.05 | $0 | |
| 08/02/2023 | Q2 2023 | -$0.17 | -$0.13 | 0.04 | $0 | |
| 05/02/2023 | Q1 2023 | -$0.16 | -$0.10 | 0.06 | $0 | |
| 02/23/2023 | Q4 2022 | -$0.15 | -$0.13 | 0.02 | $0 | |
| 11/01/2022 | Q3 2022 | -$0.14 | -$0.11 | 0.03 | $0 | |
| 08/02/2022 | Q2 2022 | -$0.17 | -$0.11 | 0.06 | $0 | |
| 05/03/2022 | Q1 2022 | -$0.15 | -$0.12 | 0.03 | $0 | |
| 02/24/2022 | Q4 2021 | -$0.15 | -$0.13 | 0.02 | $0 | |
| 11/02/2021 | Q3 2021 | -$0.11 | -$0.12 | -0.01 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.09 | -$0.09 | 0 | $0 | |
| 05/13/2021 | Q1 2021 | -$0.07 | $0 | |||
| 03/30/2021 | Q4 2020 | -$0.17 | $0 | |||
| 11/13/2020 | Q3 2020 | -$0.13 | $0 | |||
| 09/18/2020 | Q2 2020 | -$0.12 | $0 | |||
| 05/08/2020 | Q1 2020 | -$0.45 | $0 | |||
| 03/06/2020 | Q4 2019 | $0.05 | $0 |
Nautilus Biotechnology, Inc. Earnings: Frequently Asked Questions
-
When is Nautilus Biotechnology, Inc.'s earnings date?
Nautilus Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did Nautilus Biotechnology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Nautilus Biotechnology, Inc. (:NAUT) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.17 by $0.04.
-
How can I listen to Nautilus Biotechnology, Inc.'s earnings conference call?
The conference call for Nautilus Biotechnology, Inc.'s latest earnings report can be listened to online.
-
How can I read Nautilus Biotechnology, Inc.'s conference call transcript?
The conference call transcript for Nautilus Biotechnology, Inc.'s latest earnings report can be read online.
-
How much profit does Nautilus Biotechnology, Inc. generate each year?
Nautilus Biotechnology, Inc. (:NAUT) has a recorded net income of $0. Nautilus Biotechnology, Inc. has generated $-0.51 earnings per share over the last four quarters.
-
What is Nautilus Biotechnology, Inc.'s price-to-earnings ratio?
Nautilus Biotechnology, Inc. (:NAUT) has a price-to-earnings ratio of -4.29 and price/earnings-to-growth ratio is -0.04.
